{
  "iteration": 102,
  "question_id": "index_101",
  "status": "SUCCESS",
  "n_chains_max": 16,
  "window_size": 2,
  "n_chains_generated": 2,
  "stopped_early": true,
  "correct_answer_reference": "D",
  "voted_answer": "D",
  "final_score": 1,
  "individual_answers": [
    "D",
    "D"
  ],
  "processing_duration_sec": 108.7135169506073,
  "usage_aggregated": {
    "prompt_tokens": 444,
    "total_completion_tokens": 8936,
    "total_tokens": 9380
  },
  "chains_details": [
    {
      "chain_index": 1,
      "reasoning_text": "Okay, let's see. I need to figure out why there's no green signal in the offspring when they were expecting it. The question is about a bicistronic vector and the expression of a receptor fused to eGFP. \n\nFirst, let me recap the setup. The construct has the ligand ORF at the 5' end fused to mCherry, and the receptor at the 3' end fused to eGFP. The ligand is under the CBA promoter, and the receptor is upstream of an IRES. Wait, no, the problem says \"upstream of the receptor is the IRES regulatory element.\" Wait, bicistronic vectors usually use IRES to allow translation of the second gene without a promoter. So maybe the ligand is driven by the CBA promoter, and the receptor is after the IRES, so it's translated from the same mRNA but using the IRES. But the ligand has a stop in a loxP-stop-loxP cassette, and the receptor has a stop in a lox2272-stop-lox2272. \n\nThe mice are bred with SOX10-Cre, which is expressed in neural crest cells. The Cre would remove the stop sequences, allowing expression of both the ligand and the receptor. But the offspring don't show green fluorescence (eGFP from the receptor). \n\nPossible reasons: Let's look at the options. \n\nOption D says the receptor and eGFP are not in frame. If the stop codon is removed by Cre, but the frames are off, then the eGFP wouldn't be expressed properly. The fusion would have a frameshift or incorrect reading frame, so the GFP wouldn't be made. \n\nOption B suggests the receptor is stuck in the Golgi. If the receptor isn't transported to the cell surface, maybe the antibody can detect it in Western blot (since total proteins are used there) but it wouldn't be visible under the microscope as a fluorescent signal. But the question mentions that the Western blot was done after transfection into astrocytes and showed signals proportional to actin. Wait, the problem states that the antibodies were raised against overexpressed proteins and tested on the Western blot after transfection. So maybe in the transfected cells, the receptor-eGFP is expressed, meaning that the construct works in vitro. So if in the mouse model it's not showing up, maybe the problem is in the expression in vivo. \n\nWait, the construct is in the mouse's genome. The bicistronic setup: ligand is under CBA, so maybe it's expressed regardless. The receptor is after IRES, but with a stop in a lox2272 cassette. The Cre would remove the stop, allowing translation of the receptor and eGFP. But if the frames are wrong between receptor and eGFP, then even if the stop is removed, the eGFP wouldn't be translated properly. So the eGFP part wouldn't be expressed. That would explain no green signal. \n\nAlternatively, option C says the enhancer is missing. But the problem states the ligand and receptor are initially expressed in neural crest cells, so maybe the promoter (CBA) is sufficient? Or maybe the IRES isn't working. Wait, the receptor is after the IRES? Wait, the setup is a bicistronic vector. Typically, the IRES is between the two ORFs so that the second gene is translated from the same mRNA. But here, the ligand is under the CBA promoter, then there's a stop in a loxP cassette. Wait, perhaps the structure is:\n\nCBA promoter --> ligand ORF --stop--loxP...loxP? Wait the problem says between the ligand ORF and mCherry there's a stop in a loxP-stop-loxP cassette. Wait maybe the ligand is fused to mCherry, but the stop is in between. Wait, the description says the ligand ORF is at the 5' position fused to mCherry. Wait, maybe the ligand is fused to mCherry via a stop that's in a loxP cassette. Let me parse the construct structure again.\n\nThe bicistronic vector has the ligand ORF at 5' fused to mCherry. Between the ligand and mCherry is a stop in a loxP-stop-loxP. So the ligand is followed by a stop, but the mCherry is after that? Wait, perhaps the ligand is the first gene, and mCherry is part of the second? Or maybe the ligand is fused to mCherry, but with a stop that can be removed. Wait, perhaps the ligand is the first part, then a loxP-stop-loxP cassette, then mCherry? No, the wording says \"the ligand ORF is at the 5' position, fused to mCherry\". So the ligand is fused to mCherry, but between them there's a stop in a loxP cassette. So maybe the ligand is followed by a stop codon (interrupting the fusion to mCherry) which can be removed by Cre. So Cre would excise the stop, allowing the ligand to be fused to mCherry? Or perhaps the mCherry is part of the second gene? Hmm, this is getting a bit tangled.\n\nAlternatively, the bicistronic vector has two genes. The ligand is the first gene, under CBA promoter, then the receptor is the second, driven by IRES. Wait the problem states: \"the ligand ORF is at the 5' position, fused to mCherry; the receptor ORF is at the 3' and fused to the eGFP at the C-terminus.\" So the ligand is fused to mCherry (so ligand-mCherry?), and the receptor is fused to eGFP (receptor-eGFP). Between the ligand and mCherry is a stop in a loxP cassette. So normally, without Cre, the ligand would be translated up to the stop, so the mCherry isn't expressed. But with Cre, the stop is removed, allowing ligand-mCherry to be expressed as a fusion protein. Similarly, between receptor and eGFP is a lox2272-stop-lox2272. So the receptor would be expressed normally (since it's 3' of IRES?), but the stop before eGFP would be removed by Cre (assuming Cre can recognize lox2272?), allowing receptor-eGFP fusion. \n\nWait, but the construct is bicistronic, so the ligand is first, followed by an IRES, then the receptor? Wait the problem says \"the receptor ORF is at the 3' and fused to the eGFP at the C-terminus.\" The IRES is upstream of the receptor. So the structure would be: CBA promoter -> ligand (with mCherry fusion via a loxP-stop-loxP) -> IRES -> receptor (with eGFP fusion via a lox2272-stop-lox2272). \n\nSo when Cre is present (from SOX10-Cre), it would remove the stops in both cassettes, allowing the ligand to be expressed as ligand-mCherry and the receptor as receptor-eGFP. The IRES would allow the receptor to be translated from the same mRNA. \n\nThe problem states that after breeding, the offspring don't show green (eGFP). The Western blot using the antibodies (raised against overexpressed proteins) showed signals proportional to actin, so in the transfected astrocytes, the proteins were expressed. So in vitro, the constructs work. But in the mice, when using Cre, the green signal isn't there. \n\nPossible issues: \n\nOption D: receptor and eGFP not in frame. If the stop is removed but the reading frame between receptor and eGFP is wrong, then the eGFP wouldn't be expressed. Even if the receptor is expressed, the eGFP part wouldn't be. So the Western blot might show receptor but no GFP? Wait, but the antibodies are against the overexpressed proteins (the receptor and ligand?), so maybe the antibody for the receptor would detect it, but the GFP wouldn't be there. However, the question states that the total proteins gave a signal proportional to actin. Wait, maybe the Western blot showed that when they transfected the plasmid into astrocytes, the constructs were expressed. So in that case, the eGFP must have been expressed in vitro. \n\nWait, but in the mouse model, when Cre is present, maybe the problem is that the receptor-eGFP isn't being expressed. If the frame is off, then the eGFP wouldn't be translated, so the Western blot might not detect the eGFP. But the problem states that the antibodies were raised against the overexpressed proteins (so maybe the antibodies are against the receptor and ligand, not the tags?), so maybe the eGFP isn't being detected by the antibody. Hmm, this is getting a bit confusing. \n\nAlternatively, the Cre might not be active. But the SOX10-Cre is expressed in neural crest cells, which are where the ligand-receptor pair is initially expressed. If the Cre was working, then the stops would be removed. \n\nAnother option is B: the receptor-eGFP is stuck in the Golgi. If the receptor is a transmembrane protein, maybe it's retained there, so it doesn't reach the cell surface. But the eGFP would still be present in the cell, so in a Western blot, you should see it. But the problem says that in the transfected cells, the construct works. So maybe in vivo, there's a problem. Alternatively, the receptor is properly expressed but the eGFP isn't because of a frameshift. \n\nOption C says the enhancer is missing. The CBA promoter is a strong promoter, so maybe the enhancer isn't necessary. \n\nOption A: paracrine relationship. If ligand and receptor are in paracrine, meaning they act on different cells, maybe the eGFP isn't expressed in the same cell. But the question is about the receptor being fused to eGFP. The absence of green would be because the receptor isn't expressed. \n\nWait, the construct has the receptor-eGFP. If the Cre removes the stop between receptor and eGFP, then the fusion should be made. If the receptor isn't being expressed, maybe the IRES isn't working. Wait the receptor is after the IRES. The ligand is under the CBA promoter, so ligand-mCherry should be expressed (if Cre is there). The receptor would be translated via IRES. But if the receptor's stop is removed, then it should be expressed. \n\nAlternatively, maybe the IRES isn't effective in that cell type. But the problem states that when they transfected the plasmid into primary astrocytes, the Western blot showed the proteins (so the IRES worked there). But neural crest cells might be different. But then why no signal? \n\nAlternatively, the frameshift (option D) would mean that even if the stop is removed, the eGFP isn't in frame. So the receptor would be expressed but the eGFP isn't. So the eGFP wouldn't be fluorescent. The Western blot using the antibody against the receptor would show the receptor, but eGFP wouldn't be detected unless the antibody is against eGFP. Wait the question says the antibodies were raised against the overexpressed proteins (the ligand and receptor), so maybe the eGFP isn't detected. But in the transfected cells, they would have expressed the receptor-eGFP (if frames are correct), so the antibody against the receptor would detect the fusion. If in the mouse, the frameshift exists, then the receptor would be truncated, not fused to eGFP, so the antibody would detect the receptor but the eGFP wouldn't be there. But the problem states that in the transfected cells, the total proteins gave a signal proportional to actin. Maybe the construct in the plasmid was correct, but in the mouse model, the insertion of the construct into the genome caused a frameshift? Wait, the problem says they bred a mouse model homozygous for the construct. So the construct is integrated into the genome correctly. \n\nHmm, perhaps the issue is that the lox2272 and loxP sites aren't compatible. Cre can recognize both, but maybe the direction is wrong. Wait, loxP and lox2272 are different variants; Cre can recombine them, but maybe the orientation matters. If the stop cassette is between the receptor and eGFP with lox2272 sites, maybe the recombination didn't occur properly. But the problem states that the Cre is present (since they crossed with SOX10-Cre). Alternatively, the stop was not removed. But why? \n\nAlternatively, the receptor-eGFP fusion is not in frame. So even if the stop is removed, the DNA sequence between receptor and eGFP is not in the same reading frame, so the eGFP would not be expressed. That would explain no green signal. The receptor would be expressed, but eGFP wouldn't. Since the question says the antibodies were tested on the transfected cells (which presumably had the correct plasmid), so the construct works in vitro, but in the mouse, maybe the construct was inserted into the genome in a way that caused a frameshift? Wait no, the construct is the same. Unless during the cloning, the fusion between receptor and eGFP was done incorrectly, leading to a frameshift. The problem states that the antibodies were raised against overexpressed proteins (so the construct was made correctly in the lab), but in the mouse, perhaps the insertion into the genome caused a frameshift? Not sure. \n\nAlternatively, the eGFP is present but not fluorescent. But the problem says they used fluorescent microscopy. \n\nThe most likely answer here is D) the receptor and eGFP are not in frame. Because if the frameshift exists, then the eGFP wouldn't be expressed, so no green signal. The Western blot in transfected cells would have shown the receptor and maybe the ligand-mCherry, but in the mouse model, the frameshift (maybe due to incorrect cloning) would prevent the eGFP from being expressed. \n\nAlternatively, option B: stuck in Golgi. But if the protein is stuck in the Golgi, the antibody would still detect it in the Western blot, but the fluorescence might not be visible if it's intracellular. However, eGFP is a tag, so even if the receptor is in the Golgi, you might see fluorescence inside the cell. Unless the construct isn't being translated at all. \n\nWait, another angle: the bicistronic setup. The ligand is under the CBA promoter, so it's translated first. The receptor is after IRES, so it's translated from the same mRNA. But the receptor has its own stop cassette. Wait, the receptor is fused to eGFP via a stop that's in a lox2272 cassette. So normally, without Cre, the receptor would be translated up to the stop, so only the receptor part. With Cre, the stop is removed, allowing receptor-eGFP fusion. \n\nIf the frameshift is there, then the eGFP wouldn't be expressed. So the receptor would be expressed, but eGFP not. So the green signal wouldn't be there. The Western blot (using antibodies against receptor) would detect the receptor, but the eGFP wouldn't be there. But in the transfected cells, since they used the same construct, the eGFP should be present. Wait, unless the problem in the mouse model is due to the genomic insertion. Wait the question states that the construct is bred into the mouse, so the construct is part of the genome. Maybe during the cloning into the genome, the fusion introduced a frameshift. \n\nAlternatively, the problem might be that the IRES isn't sufficient for translation of the receptor. But the problem says in the transfected astrocytes, the construct worked (so IRES worked there). \n\nTherefore, the most likely answer is D. The frameshift would prevent eGFP from being expressed, leading to no green signal.\n",
      "final_answer_text": "\n\nThe bicistronic vector design includes a stop codon between the receptor and eGFP, flanked by lox2272 sites. SOX10-Cre mice would excise this stop, allowing translation of the receptor-eGFP fusion. However, if the receptor and eGFP are not in frame after excision, the eGFP would not be expressed properly, resulting in no green fluorescence. The Western blot confirmed construct functionality in vitro, implying the issue arises from a frameshift in vivo. Other options, like Golgi retention (B) or missing enhancers (C), would not fully explain the absence of fluorescence given the Cre-mediated excision and promoter activity. A paracrine relationship (A) does not directly affect the receptor's eGFP expression. Thus, the frameshift (D) is the most plausible explanation.\n\nAnswer: D",
      "full_content": "Okay, let's see. I need to figure out why there's no green signal in the offspring when they were expecting it. The question is about a bicistronic vector and the expression of a receptor fused to eGFP. \n\nFirst, let me recap the setup. The construct has the ligand ORF at the 5' end fused to mCherry, and the receptor at the 3' end fused to eGFP. The ligand is under the CBA promoter, and the receptor is upstream of an IRES. Wait, no, the problem says \"upstream of the receptor is the IRES regulatory element.\" Wait, bicistronic vectors usually use IRES to allow translation of the second gene without a promoter. So maybe the ligand is driven by the CBA promoter, and the receptor is after the IRES, so it's translated from the same mRNA but using the IRES. But the ligand has a stop in a loxP-stop-loxP cassette, and the receptor has a stop in a lox2272-stop-lox2272. \n\nThe mice are bred with SOX10-Cre, which is expressed in neural crest cells. The Cre would remove the stop sequences, allowing expression of both the ligand and the receptor. But the offspring don't show green fluorescence (eGFP from the receptor). \n\nPossible reasons: Let's look at the options. \n\nOption D says the receptor and eGFP are not in frame. If the stop codon is removed by Cre, but the frames are off, then the eGFP wouldn't be expressed properly. The fusion would have a frameshift or incorrect reading frame, so the GFP wouldn't be made. \n\nOption B suggests the receptor is stuck in the Golgi. If the receptor isn't transported to the cell surface, maybe the antibody can detect it in Western blot (since total proteins are used there) but it wouldn't be visible under the microscope as a fluorescent signal. But the question mentions that the Western blot was done after transfection into astrocytes and showed signals proportional to actin. Wait, the problem states that the antibodies were raised against overexpressed proteins and tested on the Western blot after transfection. So maybe in the transfected cells, the receptor-eGFP is expressed, meaning that the construct works in vitro. So if in the mouse model it's not showing up, maybe the problem is in the expression in vivo. \n\nWait, the construct is in the mouse's genome. The bicistronic setup: ligand is under CBA, so maybe it's expressed regardless. The receptor is after IRES, but with a stop in a lox2272 cassette. The Cre would remove the stop, allowing translation of the receptor and eGFP. But if the frames are wrong between receptor and eGFP, then even if the stop is removed, the eGFP wouldn't be translated properly. So the eGFP part wouldn't be expressed. That would explain no green signal. \n\nAlternatively, option C says the enhancer is missing. But the problem states the ligand and receptor are initially expressed in neural crest cells, so maybe the promoter (CBA) is sufficient? Or maybe the IRES isn't working. Wait, the receptor is after the IRES? Wait, the setup is a bicistronic vector. Typically, the IRES is between the two ORFs so that the second gene is translated from the same mRNA. But here, the ligand is under the CBA promoter, then there's a stop in a loxP cassette. Wait, perhaps the structure is:\n\nCBA promoter --> ligand ORF --stop--loxP...loxP? Wait the problem says between the ligand ORF and mCherry there's a stop in a loxP-stop-loxP cassette. Wait maybe the ligand is fused to mCherry, but the stop is in between. Wait, the description says the ligand ORF is at the 5' position fused to mCherry. Wait, maybe the ligand is fused to mCherry via a stop that's in a loxP cassette. Let me parse the construct structure again.\n\nThe bicistronic vector has the ligand ORF at 5' fused to mCherry. Between the ligand and mCherry is a stop in a loxP-stop-loxP. So the ligand is followed by a stop, but the mCherry is after that? Wait, perhaps the ligand is the first gene, and mCherry is part of the second? Or maybe the ligand is fused to mCherry, but with a stop that can be removed. Wait, perhaps the ligand is the first part, then a loxP-stop-loxP cassette, then mCherry? No, the wording says \"the ligand ORF is at the 5' position, fused to mCherry\". So the ligand is fused to mCherry, but between them there's a stop in a loxP cassette. So maybe the ligand is followed by a stop codon (interrupting the fusion to mCherry) which can be removed by Cre. So Cre would excise the stop, allowing the ligand to be fused to mCherry? Or perhaps the mCherry is part of the second gene? Hmm, this is getting a bit tangled.\n\nAlternatively, the bicistronic vector has two genes. The ligand is the first gene, under CBA promoter, then the receptor is the second, driven by IRES. Wait the problem states: \"the ligand ORF is at the 5' position, fused to mCherry; the receptor ORF is at the 3' and fused to the eGFP at the C-terminus.\" So the ligand is fused to mCherry (so ligand-mCherry?), and the receptor is fused to eGFP (receptor-eGFP). Between the ligand and mCherry is a stop in a loxP cassette. So normally, without Cre, the ligand would be translated up to the stop, so the mCherry isn't expressed. But with Cre, the stop is removed, allowing ligand-mCherry to be expressed as a fusion protein. Similarly, between receptor and eGFP is a lox2272-stop-lox2272. So the receptor would be expressed normally (since it's 3' of IRES?), but the stop before eGFP would be removed by Cre (assuming Cre can recognize lox2272?), allowing receptor-eGFP fusion. \n\nWait, but the construct is bicistronic, so the ligand is first, followed by an IRES, then the receptor? Wait the problem says \"the receptor ORF is at the 3' and fused to the eGFP at the C-terminus.\" The IRES is upstream of the receptor. So the structure would be: CBA promoter -> ligand (with mCherry fusion via a loxP-stop-loxP) -> IRES -> receptor (with eGFP fusion via a lox2272-stop-lox2272). \n\nSo when Cre is present (from SOX10-Cre), it would remove the stops in both cassettes, allowing the ligand to be expressed as ligand-mCherry and the receptor as receptor-eGFP. The IRES would allow the receptor to be translated from the same mRNA. \n\nThe problem states that after breeding, the offspring don't show green (eGFP). The Western blot using the antibodies (raised against overexpressed proteins) showed signals proportional to actin, so in the transfected astrocytes, the proteins were expressed. So in vitro, the constructs work. But in the mice, when using Cre, the green signal isn't there. \n\nPossible issues: \n\nOption D: receptor and eGFP not in frame. If the stop is removed but the reading frame between receptor and eGFP is wrong, then the eGFP wouldn't be expressed. Even if the receptor is expressed, the eGFP part wouldn't be. So the Western blot might show receptor but no GFP? Wait, but the antibodies are against the overexpressed proteins (the receptor and ligand?), so maybe the antibody for the receptor would detect it, but the GFP wouldn't be there. However, the question states that the total proteins gave a signal proportional to actin. Wait, maybe the Western blot showed that when they transfected the plasmid into astrocytes, the constructs were expressed. So in that case, the eGFP must have been expressed in vitro. \n\nWait, but in the mouse model, when Cre is present, maybe the problem is that the receptor-eGFP isn't being expressed. If the frame is off, then the eGFP wouldn't be translated, so the Western blot might not detect the eGFP. But the problem states that the antibodies were raised against the overexpressed proteins (so maybe the antibodies are against the receptor and ligand, not the tags?), so maybe the eGFP isn't being detected by the antibody. Hmm, this is getting a bit confusing. \n\nAlternatively, the Cre might not be active. But the SOX10-Cre is expressed in neural crest cells, which are where the ligand-receptor pair is initially expressed. If the Cre was working, then the stops would be removed. \n\nAnother option is B: the receptor-eGFP is stuck in the Golgi. If the receptor is a transmembrane protein, maybe it's retained there, so it doesn't reach the cell surface. But the eGFP would still be present in the cell, so in a Western blot, you should see it. But the problem says that in the transfected cells, the construct works. So maybe in vivo, there's a problem. Alternatively, the receptor is properly expressed but the eGFP isn't because of a frameshift. \n\nOption C says the enhancer is missing. The CBA promoter is a strong promoter, so maybe the enhancer isn't necessary. \n\nOption A: paracrine relationship. If ligand and receptor are in paracrine, meaning they act on different cells, maybe the eGFP isn't expressed in the same cell. But the question is about the receptor being fused to eGFP. The absence of green would be because the receptor isn't expressed. \n\nWait, the construct has the receptor-eGFP. If the Cre removes the stop between receptor and eGFP, then the fusion should be made. If the receptor isn't being expressed, maybe the IRES isn't working. Wait the receptor is after the IRES. The ligand is under the CBA promoter, so ligand-mCherry should be expressed (if Cre is there). The receptor would be translated via IRES. But if the receptor's stop is removed, then it should be expressed. \n\nAlternatively, maybe the IRES isn't effective in that cell type. But the problem states that when they transfected the plasmid into primary astrocytes, the Western blot showed the proteins (so the IRES worked there). But neural crest cells might be different. But then why no signal? \n\nAlternatively, the frameshift (option D) would mean that even if the stop is removed, the eGFP isn't in frame. So the receptor would be expressed but the eGFP isn't. So the eGFP wouldn't be fluorescent. The Western blot using the antibody against the receptor would show the receptor, but eGFP wouldn't be detected unless the antibody is against eGFP. Wait the question says the antibodies were raised against the overexpressed proteins (the ligand and receptor), so maybe the eGFP isn't detected. But in the transfected cells, they would have expressed the receptor-eGFP (if frames are correct), so the antibody against the receptor would detect the fusion. If in the mouse, the frameshift exists, then the receptor would be truncated, not fused to eGFP, so the antibody would detect the receptor but the eGFP wouldn't be there. But the problem states that in the transfected cells, the total proteins gave a signal proportional to actin. Maybe the construct in the plasmid was correct, but in the mouse model, the insertion of the construct into the genome caused a frameshift? Wait, the problem says they bred a mouse model homozygous for the construct. So the construct is integrated into the genome correctly. \n\nHmm, perhaps the issue is that the lox2272 and loxP sites aren't compatible. Cre can recognize both, but maybe the direction is wrong. Wait, loxP and lox2272 are different variants; Cre can recombine them, but maybe the orientation matters. If the stop cassette is between the receptor and eGFP with lox2272 sites, maybe the recombination didn't occur properly. But the problem states that the Cre is present (since they crossed with SOX10-Cre). Alternatively, the stop was not removed. But why? \n\nAlternatively, the receptor-eGFP fusion is not in frame. So even if the stop is removed, the DNA sequence between receptor and eGFP is not in the same reading frame, so the eGFP would not be expressed. That would explain no green signal. The receptor would be expressed, but eGFP wouldn't. Since the question says the antibodies were tested on the transfected cells (which presumably had the correct plasmid), so the construct works in vitro, but in the mouse, maybe the construct was inserted into the genome in a way that caused a frameshift? Wait no, the construct is the same. Unless during the cloning, the fusion between receptor and eGFP was done incorrectly, leading to a frameshift. The problem states that the antibodies were raised against overexpressed proteins (so the construct was made correctly in the lab), but in the mouse, perhaps the insertion into the genome caused a frameshift? Not sure. \n\nAlternatively, the eGFP is present but not fluorescent. But the problem says they used fluorescent microscopy. \n\nThe most likely answer here is D) the receptor and eGFP are not in frame. Because if the frameshift exists, then the eGFP wouldn't be expressed, so no green signal. The Western blot in transfected cells would have shown the receptor and maybe the ligand-mCherry, but in the mouse model, the frameshift (maybe due to incorrect cloning) would prevent the eGFP from being expressed. \n\nAlternatively, option B: stuck in Golgi. But if the protein is stuck in the Golgi, the antibody would still detect it in the Western blot, but the fluorescence might not be visible if it's intracellular. However, eGFP is a tag, so even if the receptor is in the Golgi, you might see fluorescence inside the cell. Unless the construct isn't being translated at all. \n\nWait, another angle: the bicistronic setup. The ligand is under the CBA promoter, so it's translated first. The receptor is after IRES, so it's translated from the same mRNA. But the receptor has its own stop cassette. Wait, the receptor is fused to eGFP via a stop that's in a lox2272 cassette. So normally, without Cre, the receptor would be translated up to the stop, so only the receptor part. With Cre, the stop is removed, allowing receptor-eGFP fusion. \n\nIf the frameshift is there, then the eGFP wouldn't be expressed. So the receptor would be expressed, but eGFP not. So the green signal wouldn't be there. The Western blot (using antibodies against receptor) would detect the receptor, but the eGFP wouldn't be there. But in the transfected cells, since they used the same construct, the eGFP should be present. Wait, unless the problem in the mouse model is due to the genomic insertion. Wait the question states that the construct is bred into the mouse, so the construct is part of the genome. Maybe during the cloning into the genome, the fusion introduced a frameshift. \n\nAlternatively, the problem might be that the IRES isn't sufficient for translation of the receptor. But the problem says in the transfected astrocytes, the construct worked (so IRES worked there). \n\nTherefore, the most likely answer is D. The frameshift would prevent eGFP from being expressed, leading to no green signal.\n\n\nThe bicistronic vector design includes a stop codon between the receptor and eGFP, flanked by lox2272 sites. SOX10-Cre mice would excise this stop, allowing translation of the receptor-eGFP fusion. However, if the receptor and eGFP are not in frame after excision, the eGFP would not be expressed properly, resulting in no green fluorescence. The Western blot confirmed construct functionality in vitro, implying the issue arises from a frameshift in vivo. Other options, like Golgi retention (B) or missing enhancers (C), would not fully explain the absence of fluorescence given the Cre-mediated excision and promoter activity. A paracrine relationship (A) does not directly affect the receptor's eGFP expression. Thus, the frameshift (D) is the most plausible explanation.\n\nAnswer: D",
      "logprobs": null,
      "finish_reason": "stop",
      "completion_tokens": 3642,
      "prompt_tokens": 444,
      "usage": {
        "prompt_tokens": 444,
        "total_tokens": 4086,
        "completion_tokens": 3642
      },
      "extracted_answer": "D"
    },
    {
      "chain_index": 2,
      "reasoning_text": "Okay, let me try to work through this question. Hmm, the question is about a genetic construct in mice and why there's no green signal after using SOX10-Cre. Let me start by breaking down the information given.\n\nSo the setup is a bicistronic lox-Cre vector. The ligand is at the 5' end, fused to mCherry, and the receptor is at the 3' end, fused to eGFP. The ligand's ORF has a stop in a loxP-stop-loxP cassette. The receptor's stop is in a lox2272-stop-lox2272. The promoter for the ligand is CBA, and the receptor has an IRES upstream. \n\nThe key here is understanding how Cre recombinase would affect these constructs. Since they used SOX10-Cre, which is expressed in neural crest cells (since the question says the ligand-receptor pair is initially expressed there), the Cre would remove the stop cassettes. Wait, but the stops are in different lox sites. LoxP and lox2272 are different, so Cre can only remove the ones it recognizes. \n\nWait, Cre can recognize loxP sites but not lox2272 unless it's a special Cre variant. Wait, no, lox2272 is a mutant form that's not recognized by standard Cre. So the ligand's stop is in loxP-stop-loxP, so Cre can recombine those, removing the stop. The receptor's stop is in lox2272-stop-lox2272, so Cre can't recombine those, so the stop remains. \n\nTherefore, the ligand would be expressed because the stop is removed (since Cre is present), so ligand-mCherry would be made. But the receptor-eGFP's stop can't be removed, so the receptor's ORF would be stopped, so the receptor and eGFP wouldn't be translated. Hence, no green signal (eGFP) but maybe mCherry is present? \n\nThe question states that after crossing to SOX10-Cre, they don't see green. The answer would relate to the receptor's eGFP not being expressed. So the receptor's stop wasn't removed because the lox sites are 2272, which Cre can't cut. So the eGFP isn't expressed. \n\nLooking at the options, D says the receptor and eGFP are not in frame. Wait, but maybe the stop remains, so the receptor isn't translated at all. Wait, the stop is between the receptor and eGFP? Wait, the problem says between the receptor and eGFP there's a stop in the lox2272 cassette. So the receptor ORF is before the stop. So if the stop isn't removed, then the receptor's translation would stop there, so the receptor isn't made, and the eGFP isn't either. But the question is about the green signal (eGFP). So since the stop isn't removed, the eGFP isn't translated, so no green. \n\nOption D says they're not in frame. That would be a problem if the fusion was messed up, but in this case, the stop is still there, so translation would terminate before eGFP. So the problem is that the stop wasn't removed. But the options don't mention the stop. Let me check the options again.\n\nOption D is \"the receptor and the eGFP are not in the frame\". If the stop is still present, then the eGFP isn't even translated. So the lack of green is because the eGFP isn't made. But why would the stop not be removed? Because Cre can't recombine lox2272. The question is asking for the most likely reason why there's no green. \n\nLooking at the options again: \n\nA) ligand and receptor in paracrine: Not directly related to no GFP. \n\nB) stuck in Golgi: Maybe, but that's a trafficking issue. The problem could be expression. \n\nC) enhancer missing: The promoters are CBA and IRES. Wait, the receptor is under IRES? Wait, the question says upstream of the receptor is the IRES. Wait, bicistronic usually uses IRES between two ORFs. Wait, the construct is bicistronic with ligand at 5', then mCherry? Wait, the ligand ORF is fused to mCherry. Wait, maybe the setup is ligand-mCherry under CBA promoter, then IRES followed by receptor-eGFP? Wait the question says: \"the ligand ORF is at the 5' position, fused to mCherry; the receptor ORF is at the 3' and fused to the eGFP at the C-terminus. The ligand is under the CBA promoter, and upstream of the receptor is the IRES regulatory element.\" So the ligand is first, under CBA. The receptor is after the IRES. So the bicistronic is CBA promoter driving ligand-mCherry, then IRES then receptor-eGFP. But the stops are in between. Wait, the ligand has a stop in loxP-stop-loxP between ligand and mCherry? Wait, between the ligand ORF and mCherry is the stop cassette. Wait, the ligand is fused to mCherry. So the ligand's ORF is followed by the stop, which is in a loxP-stop-loxP. So the ligand's ORF is before the stop. So with Cre, the stop is removed, so ligand is fused to mCherry? Or is the ligand ORF followed by a stop, which when removed allows the mCherry to be expressed? Wait maybe the structure is ligand-ORF-stop-loxP... no, the exact wording is between the ligand ORF and mCherry there's a stop in the loxP-stop-loxP. So the ligand ORF is followed by a stop, then mCherry? No, perhaps the ligand is fused to mCherry, but the stop is between them, so normally the ligand is translated, then the stop prevents mCherry. But with Cre, the stop is removed, so ligand-mCherry is expressed as a fusion. \n\nSimilarly, the receptor ORF is followed by a stop in lox2272, so between receptor and eGFP. So normally, the receptor is translated, then a stop, so eGFP isn't. But with Cre, if the stop is removed, then receptor-eGFP would be expressed. But since the receptor's stop is in lox2272, Cre can't remove it. So the receptor's stop remains, so the eGFP isn't translated. Therefore, the eGFP isn't present, so no green signal. \n\nThe options: D says receptor and eGFP are not in frame. But if the stop is there, they aren't even translated, so the frame is irrelevant. The problem is the stop wasn't removed. The question is, why no green? Because the eGFP wasn't made. The reason is because the stop in the receptor's cassette (lox2272) wasn't removed by Cre. But the options don't have that. Let me check the options again.\n\nHmm, looking again:\n\nOption D says the receptor and eGFP are not in frame. That would be a problem if the fusion was not properly made. But in this case, the stop is still present, so the eGFP isn't translated at all. So the problem is the stop wasn't removed, but that's not listed. Wait, maybe I made a mistake here.\n\nAlternatively, perhaps the bicistronic construct uses IRES for the receptor. Wait, the CBA promoter is driving the ligand-mCherry (with the stop that can be removed by Cre). Then the IRES is upstream of the receptor, so maybe the receptor-eGFP is after the IRES. Wait, the description says \"the receptor ORF is at the 3' and fused to the eGFP at the C-terminus. The ligand is under the CBA promoter, and upstream of the receptor is the IRES regulatory element.\" So the structure is: CBA promoter -> ligand ORF -> (stop cassette between ligand and mCherry?), then mCherry? Wait, no. The ligand is fused to mCherry, but with a stop in between. Wait, perhaps the ligand's ORF is followed by a stop, then mCherry is after that, but with Cre removing the stop, allowing the ligand and mCherry to be in frame. But the receptor is after an IRES. So the receptor's part is after the IRES, so the receptor-eGFP would be a separate ORF. But the stop between the receptor and eGFP is in lox2272, so Cre can't remove it. So the receptor would be translated but the eGFP wouldn't. So the receptor is made, but eGFP isn't. Thus, no green. \n\nWait, but the question states that the receptor is fused to eGFP at the C-terminus. So the normal construct would have the receptor's C-terminus fused to eGFP. But if the stop is between them and not removed, then the eGFP isn't translated. Therefore, the eGFP isn't present, so no green. \n\nThe options given: \n\nOption D says the receptor and eGFP are not in frame. That could be if the stop was removed but the reading frame is messed up. But in this case, the stop isn't removed, so the eGFP isn't even translated. So the problem is the stop wasn't removed. But the options don't have an option about the lox sites. \n\nWait, maybe I misread the setup. Let me check again. \n\nThe ligand's stop is in loxP-stop-loxP. The receptor's stop is in lox2272-stop-lox2272. \n\nWhen you cross with SOX10-Cre, which is expressed in neural crest cells, the Cre would recognize loxP sites but not lox2272. So for the ligand part, the stop is flanked by loxP, so Cre removes the stop, allowing ligand and mCherry to be expressed as a fusion. \n\nFor the receptor part, the stop is in lox2272, which Cre can't recombine. So the stop remains, meaning the receptor's translation stops before reaching the eGFP. Thus, the receptor isn't fused to eGFP; in fact, the eGFP isn't translated at all. \n\nTherefore, the eGFP isn't present, so no green signal. \n\nThe options: looking for why there's no green. The possible answers:\n\nA) Paracrine: That would mean ligand and receptor act at a distance, but that wouldn't prevent the receptor from being expressed. \n\nB) Receptor stuck in Golgi: Maybe, but the problem is expression. \n\nC) Enhancer missing: The promoters are CBA and IRES, but maybe the IRES isn't sufficient. Wait, the receptor is after IRES, so even without Cre, the receptor might be expressed via IRES. Wait, but the stop is between receptor and eGFP. Wait, the receptor is fused to eGFP via the stop cassette. So if the stop is there, then the receptor can't be translated beyond the stop. Wait, the receptor's ORF is followed by a stop in the lox2272 cassette. So the receptor's own stop would prevent it from being translated past that. So the receptor itself might not be expressed either? Wait, the receptor's ORF is before the stop. So the receptor would be translated until the stop, so the receptor protein would be made (without eGFP), but the eGFP isn't. \n\nSo the eGFP isn't present, so no green. \n\nThe question is why no green. The eGFP isn't made. The reason is because the stop wasn't removed, so the eGFP part isn't translated. \n\nLooking at the options again. Option D says the receptor and eGFP are not in frame. If the stop is there, they aren't in frame because the translation stops. But if the stop is there, the eGFP isn't even translated. The frame issue would be a separate problem. The actual problem here is that the stop wasn't removed. But the options don't have that. \n\nHmm, perhaps I made a mistake. Let me check the options again. \n\nOption D: \"the receptor and the eGFP are not in the frame\". That would mean that even if the stop was removed, the proteins are not in frame. So maybe the fusion is messed up. But in this case, the stop remains, so the eGFP isn't even translated, so the frame is irrelevant. \n\nAlternatively, maybe the problem is that the receptor's expression requires the stop being removed, but since it's not, the receptor isn't made. But the eGFP is part of the same cassette. Wait, the receptor is fused to eGFP via the stop. If the stop isn't removed, then the receptor can't be translated past the stop. So the receptor's own ORF ends at the stop, so the receptor itself isn't made either. \n\nWait, but the question says the ligand and receptor were initially expressed in neural crest cells. Maybe the receptor is under IRES. Wait, the setup is the bicistronic vector with ligand (CBA promoter) and then IRES leading to receptor. So the receptor is expressed via IRES even without Cre? But the receptor has a stop between it and eGFP. Wait, the receptor's own ORF is followed by a stop, so even without Cre, the receptor would be translated normally (since the stop is between receptor and eGFP, so the receptor's own stop is not part of that). Wait, maybe I'm misunderstanding the structure. \n\nLet me parse the construct structure again. \n\nThe bicistronic vector: \n\n5' end: ligand ORF fused to mCherry, but between them is a stop in a loxP-stop-loxP cassette. So the ligand is followed by a stop, then mCherry. But with Cre, the stop is removed, so ligand and mCherry are in frame. \n\nThen the receptor ORF is at the 3' end, fused to eGFP at the C-terminus. Between them is a stop in a lox2272 cassette. So the receptor is followed by a stop, then eGFP. Since Cre can't recombine lox2272, the stop remains, so the receptor is translated up to the stop, and eGFP isn't. \n\nThe IRES is upstream of the receptor, so the receptor is part of the bicistronic setup. Wait, the IRES is upstream of the receptor, so the receptor is translated via IRES from the same mRNA as the ligand? Or is the bicistronic setup that the ligand is first, then IRES then receptor? \n\nThe question says \"the ligand ORF is at the 5' position, fused to mCherry; the receptor ORF is at the 3' and fused to the eGFP at the C-terminus. The ligand is under the CBA promoter, and upstream of the receptor is the IRES regulatory element.\" \n\nAh, so the structure is: \n\nCBA promoter -> ligand ORF (with mCherry linked via a stop that can be removed by Cre) -> then IRES -> receptor ORF (with eGFP linked via a stop that can't be removed by Cre). \n\nWait, no, the IRES is upstream of the receptor, so the receptor is after the IRES. So the ligand is first under CBA, then IRES drives the receptor. But the receptor's own stop is between it and eGFP. \n\nWait, perhaps the receptor's ORF is followed by the stop (in lox2272), so the receptor itself is translated, but the eGFP isn't. The eGFP is only expressed if the stop is removed. Since it's not, eGFP isn't. So the receptor is present (without eGFP), but the eGFP isn't. \n\nTherefore, the eGFP isn't present, so no green. The reason is that the stop between receptor and eGFP wasn't removed. \n\nThe options don't directly mention the stop not being removed. The closest might be D, but D is about being out of frame. Alternatively, maybe the problem is that the receptor's expression requires the IRES, but without the stop being removed, the receptor is made but not the eGFP. \n\nWait, the question says the receptor is fused to eGFP at the C-terminus. So the intended construct is that when the stop is removed, the receptor and eGFP are in frame. But if the stop remains, they aren't. So the eGFP isn't made. \n\nThe options: \n\nD) receptor and eGFP not in frame. If the stop is there, then they are not in frame. Because the stop would cause translation to terminate before reaching the eGFP. So the receptor is translated up to the stop, then the eGFP isn't. Therefore, the eGFP isn't made. So the reason for no green is that the eGFP wasn't expressed because the stop wasn't removed. But the option D says the fusion isn't in frame. \n\nAlternatively, maybe the stop is a stop codon, so the eGFP isn't translated. So the eGFP is not made. The problem is the stop wasn't removed, so the eGFP isn't made. The reason is that the stop between the receptor and eGFP wasn't removed. But the options don't have that. \n\nHmm, perhaps the answer is D because the stop is still there, making them not in frame. Because if the stop is present, the eGFP isn't part of the translation. So the fusion isn't possible. \n\nAlternatively, maybe the stop is between the receptor and eGFP, so when the stop is there, the eGFP isn't translated, so the receptor is expressed without the eGFP, and the eGFP isn't. So the green signal (eGFP) is absent. \n\nThe options given don't have an option about the lox2272 not being recombined. The question must have the answer as D, maybe. \n\nAlternatively, maybe option B: the receptor-eGFP is stuck in Golgi. But why? The receptor is a transmembrane protein. If the stop is present, the eGFP isn't made, so the receptor might be expressed normally (without eGFP), but the eGFP isn't. So the problem is the eGFP isn't present. \n\nAlternatively, maybe the receptor and eGFP are not in frame. If the stop is there, the eGFP isn't part of the translation. So the eGFP isn't made, but the receptor is. But the eGFP is needed for the green signal. So the reason there's no green is because the eGFP isn't made. The reason is that the stop wasn't removed. But the options don't have that. \n\nWait, perhaps the problem is that the receptor's expression requires the IRES, but the stop in the receptor's part is still there. Wait, the IRES would drive the receptor's translation, but the stop between receptor and eGFP is there, so the receptor is translated but not the eGFP. \n\nThe answer must be D? Or perhaps another option. \n\nLooking at the options again:\n\nA) Paracrine: Not related to expression. \n\nB) Stuck in Golgi: If the receptor isn't made (because of the stop?), but the receptor might be made without eGFP. \n\nC) Enhancer missing: The promoters are present, so maybe not. \n\nD) Not in frame. The stop would mean that the eGFP isn't translated, so the frame is irrelevant. But if the stop wasn't there, they would be in frame. Since the stop is there, they are not in frame for eGFP. \n\nWait, the stop is a stop codon. So the eGFP isn't translated. So the receptor is made, but eGFP isn't. So the eGFP isn't present. The lack of green is because the eGFP isn't made. The reason is the stop wasn't removed. But the options don't mention that. \n\nHmm, maybe I'm missing something. Let me think again. \n\nThe construct is designed such that Cre would remove the stop in the ligand's part (using loxP) but not the receptor's (lox2272). So the ligand-mCherry is expressed (green?), wait no, mCherry is red. The eGFP is green. \n\nWait the question says after crossing to SOX10-Cre, they don't see green (eGFP). The ligand's part would have mCherry, which is red. The receptor's eGFP isn't made because the stop wasn't removed. \n\nThe problem is that the eGFP isn't made. The reason is that the stop between the receptor and eGFP wasn't removed, so the eGFP isn't translated. \n\nThe options don't have that. The only possible option that could relate is D, if the stop being present caused the eGFP to be out of frame. But the stop is a stop codon, so the eGFP isn't translated at all. \n\nAlternatively, maybe the fusion is not in frame even without the stop? But the question says between them is a stop in a cassette. So when the stop is there, the eGFP isn't part of the translation. So the eGFP isn't made. \n\nThe answer must be D. Because the stop remains, so the eGFP isn't made. But D says \"not in frame\", which would be true if the stop is there. Because the eGFP's coding sequence isn't translated, so the receptor and eGFP aren't in frame. \n\nAlternatively, the stop causes the translation to end before eGFP, so they aren't in frame. Therefore, the correct answer is D. \n\nAlternatively, maybe the answer is C. The enhancer missing? The promoters are CBA and IRES. Wait, IRES doesn't need a promoter. The CBA is for the ligand, and the receptor is after IRES, so IRES allows translation of the second ORF. But if the stop is there, the eGFP isn't made. \n\nHmm, I think the answer is D. Because the stop remains, so the eGFP isn't in frame with the receptor. Or perhaps the stop is in the middle, so the eGFP isn't translated, so the fusion isn't made. \n\nAlternatively, maybe the eGFP isn't expressed because the receptor's translation stops at the stop codon, so the eGFP isn't part of the protein. Thus, no eGFP, so no green. \n\nThe options don't have an option about the stop not being removed. The question must be pointing to D because the stop is present, so the eGFP isn't in frame. \n\nSo I'll go with D.\n",
      "final_answer_text": "\n\nThe bicistronic construct uses loxP and lox2272 sites to control expression of the ligand-mCherry and receptor-eGFP fusions. SOX10-Cre mice express Cre recombinase, which removes sequences flanked by loxP but not lox2272. The ligand-mCherry stop cassette (loxP-flanked) is removed, allowing expression of ligand-mCherry. However, the receptor-eGFP stop cassette is flanked by lox2272, so Cre cannot remove it. This leaves a stop codon between the receptor and eGFP, preventing translation of eGFP. The absence of eGFP expression explains the lack of green signal. \n\nOption D states \"the receptor and the eGFP are not in the frame.\" While the stop codon prevents eGFP translation entirely, this phrasing is the closest match to the issue, as the stop prevents the receptor and eGFP from being translated as a single fusion protein. Other options are less relevant: paracrine signaling (A) doesn\u2019t affect expression, Golgi retention (B) is unrelated to the stop cassette, and enhancer absence (C) is incorrect since promoters are present. \n\nAnswer: D",
      "full_content": "Okay, let me try to work through this question. Hmm, the question is about a genetic construct in mice and why there's no green signal after using SOX10-Cre. Let me start by breaking down the information given.\n\nSo the setup is a bicistronic lox-Cre vector. The ligand is at the 5' end, fused to mCherry, and the receptor is at the 3' end, fused to eGFP. The ligand's ORF has a stop in a loxP-stop-loxP cassette. The receptor's stop is in a lox2272-stop-lox2272. The promoter for the ligand is CBA, and the receptor has an IRES upstream. \n\nThe key here is understanding how Cre recombinase would affect these constructs. Since they used SOX10-Cre, which is expressed in neural crest cells (since the question says the ligand-receptor pair is initially expressed there), the Cre would remove the stop cassettes. Wait, but the stops are in different lox sites. LoxP and lox2272 are different, so Cre can only remove the ones it recognizes. \n\nWait, Cre can recognize loxP sites but not lox2272 unless it's a special Cre variant. Wait, no, lox2272 is a mutant form that's not recognized by standard Cre. So the ligand's stop is in loxP-stop-loxP, so Cre can recombine those, removing the stop. The receptor's stop is in lox2272-stop-lox2272, so Cre can't recombine those, so the stop remains. \n\nTherefore, the ligand would be expressed because the stop is removed (since Cre is present), so ligand-mCherry would be made. But the receptor-eGFP's stop can't be removed, so the receptor's ORF would be stopped, so the receptor and eGFP wouldn't be translated. Hence, no green signal (eGFP) but maybe mCherry is present? \n\nThe question states that after crossing to SOX10-Cre, they don't see green. The answer would relate to the receptor's eGFP not being expressed. So the receptor's stop wasn't removed because the lox sites are 2272, which Cre can't cut. So the eGFP isn't expressed. \n\nLooking at the options, D says the receptor and eGFP are not in frame. Wait, but maybe the stop remains, so the receptor isn't translated at all. Wait, the stop is between the receptor and eGFP? Wait, the problem says between the receptor and eGFP there's a stop in the lox2272 cassette. So the receptor ORF is before the stop. So if the stop isn't removed, then the receptor's translation would stop there, so the receptor isn't made, and the eGFP isn't either. But the question is about the green signal (eGFP). So since the stop isn't removed, the eGFP isn't translated, so no green. \n\nOption D says they're not in frame. That would be a problem if the fusion was messed up, but in this case, the stop is still there, so translation would terminate before eGFP. So the problem is that the stop wasn't removed. But the options don't mention the stop. Let me check the options again.\n\nOption D is \"the receptor and the eGFP are not in the frame\". If the stop is still present, then the eGFP isn't even translated. So the lack of green is because the eGFP isn't made. But why would the stop not be removed? Because Cre can't recombine lox2272. The question is asking for the most likely reason why there's no green. \n\nLooking at the options again: \n\nA) ligand and receptor in paracrine: Not directly related to no GFP. \n\nB) stuck in Golgi: Maybe, but that's a trafficking issue. The problem could be expression. \n\nC) enhancer missing: The promoters are CBA and IRES. Wait, the receptor is under IRES? Wait, the question says upstream of the receptor is the IRES. Wait, bicistronic usually uses IRES between two ORFs. Wait, the construct is bicistronic with ligand at 5', then mCherry? Wait, the ligand ORF is fused to mCherry. Wait, maybe the setup is ligand-mCherry under CBA promoter, then IRES followed by receptor-eGFP? Wait the question says: \"the ligand ORF is at the 5' position, fused to mCherry; the receptor ORF is at the 3' and fused to the eGFP at the C-terminus. The ligand is under the CBA promoter, and upstream of the receptor is the IRES regulatory element.\" So the ligand is first, under CBA. The receptor is after the IRES. So the bicistronic is CBA promoter driving ligand-mCherry, then IRES then receptor-eGFP. But the stops are in between. Wait, the ligand has a stop in loxP-stop-loxP between ligand and mCherry? Wait, between the ligand ORF and mCherry is the stop cassette. Wait, the ligand is fused to mCherry. So the ligand's ORF is followed by the stop, which is in a loxP-stop-loxP. So the ligand's ORF is before the stop. So with Cre, the stop is removed, so ligand is fused to mCherry? Or is the ligand ORF followed by a stop, which when removed allows the mCherry to be expressed? Wait maybe the structure is ligand-ORF-stop-loxP... no, the exact wording is between the ligand ORF and mCherry there's a stop in the loxP-stop-loxP. So the ligand ORF is followed by a stop, then mCherry? No, perhaps the ligand is fused to mCherry, but the stop is between them, so normally the ligand is translated, then the stop prevents mCherry. But with Cre, the stop is removed, so ligand-mCherry is expressed as a fusion. \n\nSimilarly, the receptor ORF is followed by a stop in lox2272, so between receptor and eGFP. So normally, the receptor is translated, then a stop, so eGFP isn't. But with Cre, if the stop is removed, then receptor-eGFP would be expressed. But since the receptor's stop is in lox2272, Cre can't remove it. So the receptor's stop remains, so the eGFP isn't translated. Therefore, the eGFP isn't present, so no green signal. \n\nThe options: D says receptor and eGFP are not in frame. But if the stop is there, they aren't even translated, so the frame is irrelevant. The problem is the stop wasn't removed. The question is, why no green? Because the eGFP wasn't made. The reason is because the stop in the receptor's cassette (lox2272) wasn't removed by Cre. But the options don't have that. Let me check the options again.\n\nHmm, looking again:\n\nOption D says the receptor and eGFP are not in frame. That would be a problem if the fusion was not properly made. But in this case, the stop is still present, so the eGFP isn't translated at all. So the problem is the stop wasn't removed, but that's not listed. Wait, maybe I made a mistake here.\n\nAlternatively, perhaps the bicistronic construct uses IRES for the receptor. Wait, the CBA promoter is driving the ligand-mCherry (with the stop that can be removed by Cre). Then the IRES is upstream of the receptor, so maybe the receptor-eGFP is after the IRES. Wait, the description says \"the receptor ORF is at the 3' and fused to the eGFP at the C-terminus. The ligand is under the CBA promoter, and upstream of the receptor is the IRES regulatory element.\" So the structure is: CBA promoter -> ligand ORF -> (stop cassette between ligand and mCherry?), then mCherry? Wait, no. The ligand is fused to mCherry, but with a stop in between. Wait, perhaps the ligand's ORF is followed by a stop, then mCherry is after that, but with Cre removing the stop, allowing the ligand and mCherry to be in frame. But the receptor is after an IRES. So the receptor's part is after the IRES, so the receptor-eGFP would be a separate ORF. But the stop between the receptor and eGFP is in lox2272, so Cre can't remove it. So the receptor would be translated but the eGFP wouldn't. So the receptor is made, but eGFP isn't. Thus, no green. \n\nWait, but the question states that the receptor is fused to eGFP at the C-terminus. So the normal construct would have the receptor's C-terminus fused to eGFP. But if the stop is between them and not removed, then the eGFP isn't translated. Therefore, the eGFP isn't present, so no green. \n\nThe options given: \n\nOption D says the receptor and eGFP are not in frame. That could be if the stop was removed but the reading frame is messed up. But in this case, the stop isn't removed, so the eGFP isn't even translated. So the problem is the stop wasn't removed. But the options don't have an option about the lox sites. \n\nWait, maybe I misread the setup. Let me check again. \n\nThe ligand's stop is in loxP-stop-loxP. The receptor's stop is in lox2272-stop-lox2272. \n\nWhen you cross with SOX10-Cre, which is expressed in neural crest cells, the Cre would recognize loxP sites but not lox2272. So for the ligand part, the stop is flanked by loxP, so Cre removes the stop, allowing ligand and mCherry to be expressed as a fusion. \n\nFor the receptor part, the stop is in lox2272, which Cre can't recombine. So the stop remains, meaning the receptor's translation stops before reaching the eGFP. Thus, the receptor isn't fused to eGFP; in fact, the eGFP isn't translated at all. \n\nTherefore, the eGFP isn't present, so no green signal. \n\nThe options: looking for why there's no green. The possible answers:\n\nA) Paracrine: That would mean ligand and receptor act at a distance, but that wouldn't prevent the receptor from being expressed. \n\nB) Receptor stuck in Golgi: Maybe, but the problem is expression. \n\nC) Enhancer missing: The promoters are CBA and IRES, but maybe the IRES isn't sufficient. Wait, the receptor is after IRES, so even without Cre, the receptor might be expressed via IRES. Wait, but the stop is between receptor and eGFP. Wait, the receptor is fused to eGFP via the stop cassette. So if the stop is there, then the receptor can't be translated beyond the stop. Wait, the receptor's ORF is followed by a stop in the lox2272 cassette. So the receptor's own stop would prevent it from being translated past that. So the receptor itself might not be expressed either? Wait, the receptor's ORF is before the stop. So the receptor would be translated until the stop, so the receptor protein would be made (without eGFP), but the eGFP isn't. \n\nSo the eGFP isn't present, so no green. \n\nThe question is why no green. The eGFP isn't made. The reason is because the stop wasn't removed, so the eGFP part isn't translated. \n\nLooking at the options again. Option D says the receptor and eGFP are not in frame. If the stop is there, they aren't in frame because the translation stops. But if the stop is there, the eGFP isn't even translated. The frame issue would be a separate problem. The actual problem here is that the stop wasn't removed. But the options don't have that. \n\nHmm, perhaps I made a mistake. Let me check the options again. \n\nOption D: \"the receptor and the eGFP are not in the frame\". That would mean that even if the stop was removed, the proteins are not in frame. So maybe the fusion is messed up. But in this case, the stop remains, so the eGFP isn't even translated, so the frame is irrelevant. \n\nAlternatively, maybe the problem is that the receptor's expression requires the stop being removed, but since it's not, the receptor isn't made. But the eGFP is part of the same cassette. Wait, the receptor is fused to eGFP via the stop. If the stop isn't removed, then the receptor can't be translated past the stop. So the receptor's own ORF ends at the stop, so the receptor itself isn't made either. \n\nWait, but the question says the ligand and receptor were initially expressed in neural crest cells. Maybe the receptor is under IRES. Wait, the setup is the bicistronic vector with ligand (CBA promoter) and then IRES leading to receptor. So the receptor is expressed via IRES even without Cre? But the receptor has a stop between it and eGFP. Wait, the receptor's own ORF is followed by a stop, so even without Cre, the receptor would be translated normally (since the stop is between receptor and eGFP, so the receptor's own stop is not part of that). Wait, maybe I'm misunderstanding the structure. \n\nLet me parse the construct structure again. \n\nThe bicistronic vector: \n\n5' end: ligand ORF fused to mCherry, but between them is a stop in a loxP-stop-loxP cassette. So the ligand is followed by a stop, then mCherry. But with Cre, the stop is removed, so ligand and mCherry are in frame. \n\nThen the receptor ORF is at the 3' end, fused to eGFP at the C-terminus. Between them is a stop in a lox2272 cassette. So the receptor is followed by a stop, then eGFP. Since Cre can't recombine lox2272, the stop remains, so the receptor is translated up to the stop, and eGFP isn't. \n\nThe IRES is upstream of the receptor, so the receptor is part of the bicistronic setup. Wait, the IRES is upstream of the receptor, so the receptor is translated via IRES from the same mRNA as the ligand? Or is the bicistronic setup that the ligand is first, then IRES then receptor? \n\nThe question says \"the ligand ORF is at the 5' position, fused to mCherry; the receptor ORF is at the 3' and fused to the eGFP at the C-terminus. The ligand is under the CBA promoter, and upstream of the receptor is the IRES regulatory element.\" \n\nAh, so the structure is: \n\nCBA promoter -> ligand ORF (with mCherry linked via a stop that can be removed by Cre) -> then IRES -> receptor ORF (with eGFP linked via a stop that can't be removed by Cre). \n\nWait, no, the IRES is upstream of the receptor, so the receptor is after the IRES. So the ligand is first under CBA, then IRES drives the receptor. But the receptor's own stop is between it and eGFP. \n\nWait, perhaps the receptor's ORF is followed by the stop (in lox2272), so the receptor itself is translated, but the eGFP isn't. The eGFP is only expressed if the stop is removed. Since it's not, eGFP isn't. So the receptor is present (without eGFP), but the eGFP isn't. \n\nTherefore, the eGFP isn't present, so no green. The reason is that the stop between receptor and eGFP wasn't removed. \n\nThe options don't directly mention the stop not being removed. The closest might be D, but D is about being out of frame. Alternatively, maybe the problem is that the receptor's expression requires the IRES, but without the stop being removed, the receptor is made but not the eGFP. \n\nWait, the question says the receptor is fused to eGFP at the C-terminus. So the intended construct is that when the stop is removed, the receptor and eGFP are in frame. But if the stop remains, they aren't. So the eGFP isn't made. \n\nThe options: \n\nD) receptor and eGFP not in frame. If the stop is there, then they are not in frame. Because the stop would cause translation to terminate before reaching the eGFP. So the receptor is translated up to the stop, then the eGFP isn't. Therefore, the eGFP isn't made. So the reason for no green is that the eGFP wasn't expressed because the stop wasn't removed. But the option D says the fusion isn't in frame. \n\nAlternatively, maybe the stop is a stop codon, so the eGFP isn't translated. So the eGFP is not made. The problem is the stop wasn't removed, so the eGFP isn't made. The reason is that the stop between the receptor and eGFP wasn't removed. But the options don't have that. \n\nHmm, perhaps the answer is D because the stop is still there, making them not in frame. Because if the stop is present, the eGFP isn't part of the translation. So the fusion isn't possible. \n\nAlternatively, maybe the stop is between the receptor and eGFP, so when the stop is there, the eGFP isn't translated, so the receptor is expressed without the eGFP, and the eGFP isn't. So the green signal (eGFP) is absent. \n\nThe options given don't have an option about the lox2272 not being recombined. The question must have the answer as D, maybe. \n\nAlternatively, maybe option B: the receptor-eGFP is stuck in Golgi. But why? The receptor is a transmembrane protein. If the stop is present, the eGFP isn't made, so the receptor might be expressed normally (without eGFP), but the eGFP isn't. So the problem is the eGFP isn't present. \n\nAlternatively, maybe the receptor and eGFP are not in frame. If the stop is there, the eGFP isn't part of the translation. So the eGFP isn't made, but the receptor is. But the eGFP is needed for the green signal. So the reason there's no green is because the eGFP isn't made. The reason is that the stop wasn't removed. But the options don't have that. \n\nWait, perhaps the problem is that the receptor's expression requires the IRES, but the stop in the receptor's part is still there. Wait, the IRES would drive the receptor's translation, but the stop between receptor and eGFP is there, so the receptor is translated but not the eGFP. \n\nThe answer must be D? Or perhaps another option. \n\nLooking at the options again:\n\nA) Paracrine: Not related to expression. \n\nB) Stuck in Golgi: If the receptor isn't made (because of the stop?), but the receptor might be made without eGFP. \n\nC) Enhancer missing: The promoters are present, so maybe not. \n\nD) Not in frame. The stop would mean that the eGFP isn't translated, so the frame is irrelevant. But if the stop wasn't there, they would be in frame. Since the stop is there, they are not in frame for eGFP. \n\nWait, the stop is a stop codon. So the eGFP isn't translated. So the receptor is made, but eGFP isn't. So the eGFP isn't present. The lack of green is because the eGFP isn't made. The reason is the stop wasn't removed. But the options don't mention that. \n\nHmm, maybe I'm missing something. Let me think again. \n\nThe construct is designed such that Cre would remove the stop in the ligand's part (using loxP) but not the receptor's (lox2272). So the ligand-mCherry is expressed (green?), wait no, mCherry is red. The eGFP is green. \n\nWait the question says after crossing to SOX10-Cre, they don't see green (eGFP). The ligand's part would have mCherry, which is red. The receptor's eGFP isn't made because the stop wasn't removed. \n\nThe problem is that the eGFP isn't made. The reason is that the stop between the receptor and eGFP wasn't removed, so the eGFP isn't translated. \n\nThe options don't have that. The only possible option that could relate is D, if the stop being present caused the eGFP to be out of frame. But the stop is a stop codon, so the eGFP isn't translated at all. \n\nAlternatively, maybe the fusion is not in frame even without the stop? But the question says between them is a stop in a cassette. So when the stop is there, the eGFP isn't part of the translation. So the eGFP isn't made. \n\nThe answer must be D. Because the stop remains, so the eGFP isn't made. But D says \"not in frame\", which would be true if the stop is there. Because the eGFP's coding sequence isn't translated, so the receptor and eGFP aren't in frame. \n\nAlternatively, the stop causes the translation to end before eGFP, so they aren't in frame. Therefore, the correct answer is D. \n\nAlternatively, maybe the answer is C. The enhancer missing? The promoters are CBA and IRES. Wait, IRES doesn't need a promoter. The CBA is for the ligand, and the receptor is after IRES, so IRES allows translation of the second ORF. But if the stop is there, the eGFP isn't made. \n\nHmm, I think the answer is D. Because the stop remains, so the eGFP isn't in frame with the receptor. Or perhaps the stop is in the middle, so the eGFP isn't translated, so the fusion isn't made. \n\nAlternatively, maybe the eGFP isn't expressed because the receptor's translation stops at the stop codon, so the eGFP isn't part of the protein. Thus, no eGFP, so no green. \n\nThe options don't have an option about the stop not being removed. The question must be pointing to D because the stop is present, so the eGFP isn't in frame. \n\nSo I'll go with D.\n\n\nThe bicistronic construct uses loxP and lox2272 sites to control expression of the ligand-mCherry and receptor-eGFP fusions. SOX10-Cre mice express Cre recombinase, which removes sequences flanked by loxP but not lox2272. The ligand-mCherry stop cassette (loxP-flanked) is removed, allowing expression of ligand-mCherry. However, the receptor-eGFP stop cassette is flanked by lox2272, so Cre cannot remove it. This leaves a stop codon between the receptor and eGFP, preventing translation of eGFP. The absence of eGFP expression explains the lack of green signal. \n\nOption D states \"the receptor and the eGFP are not in the frame.\" While the stop codon prevents eGFP translation entirely, this phrasing is the closest match to the issue, as the stop prevents the receptor and eGFP from being translated as a single fusion protein. Other options are less relevant: paracrine signaling (A) doesn\u2019t affect expression, Golgi retention (B) is unrelated to the stop cassette, and enhancer absence (C) is incorrect since promoters are present. \n\nAnswer: D",
      "logprobs": null,
      "finish_reason": "stop",
      "completion_tokens": 5294,
      "prompt_tokens": 444,
      "usage": {
        "prompt_tokens": 444,
        "total_tokens": 5738,
        "completion_tokens": 5294
      },
      "extracted_answer": "D"
    }
  ],
  "avg_kv_cache_usage": 0.01636729365009345,
  "max_kv_cache_usage": 0.0290808999521302
}